A Phase 1, Multicenter, Open-Label, Safety Study of AG-120 or AG-221 in Combination with Induction Therapy and Consolidation Therapy in Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 and/or IDH2 August 17, 2017 Sponsor Agios Protocol Number AG120-221-C-001 To Learn More Call 201-510-0910